Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.
2.

Evaluation of Xpert® MTB/RIF and Ustar EasyNAT™ TB IAD for diagnosis of tuberculous lymphadenitis of children in Tanzania: a prospective descriptive study.

Bholla M, Kapalata N, Masika E, Chande H, Jugheli L, Sasamalo M, Glass TR, Beck HP, Reither K.

BMC Infect Dis. 2016 Jun 6;16:246. doi: 10.1186/s12879-016-1578-z.

3.

Same day ART initiation versus clinic-based pre-ART assessment and counselling for individuals newly tested HIV-positive during community-based HIV testing in rural Lesotho - a randomized controlled trial (CASCADE trial).

Labhardt ND, Ringera I, Lejone TI, Masethothi P, Thaanyane T, Kamele M, Gupta RS, Thin K, Cerutti B, Klimkait T, Fritz C, Glass TR.

BMC Public Health. 2016 Apr 14;16:329. doi: 10.1186/s12889-016-2972-6.

4.

Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality.

Glass TR, Sterne JA, Schneider MP, De Geest S, Nicca D, Furrer H, Günthard HF, Bernasconi E, Calmy A, Rickenbach M, Battegay M, Bucher HC; Swiss HIV Cohort Study.

AIDS. 2015 Oct 23;29(16):2195-200. doi: 10.1097/QAD.0000000000000782.

PMID:
26544582
5.

Evaluation of Giant African Pouched Rats for Detection of Pulmonary Tuberculosis in Patients from a High-Endemic Setting.

Reither K, Jugheli L, Glass TR, Sasamalo M, Mhimbira FA, Weetjens BJ, Cox C, Edwards TL, Mulder C, Beyene NW, Mahoney A.

PLoS One. 2015 Oct 7;10(10):e0135877. doi: 10.1371/journal.pone.0135877. eCollection 2015.

6.

Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality.

Letang E, Müller MC, Ntamatungiro AJ, Kimera N, Faini D, Furrer H, Battegay M, Tanner M, Hatz C, Boulware DR, Glass TR.

Open Forum Infect Dis. 2015 Apr 2;2(2):ofv046. doi: 10.1093/ofid/ofv046. eCollection 2015 Apr.

7.

Correction: A Bundle of Services Increased Ascertainment of Tuberculosis among HIV-Infected Individuals Enrolled in a HIV Cohort in Rural Sub-Saharan Africa.

Haraka F, Glass TR, Sikalengo G, Gamell A, Ntamatungiro A, Hatz C, Tanner M, Furrer H, Battegay M, Letang E.

PLoS One. 2015 May 20;10(5):e0129185. doi: 10.1371/journal.pone.0129185. eCollection 2015. No abstract available.

8.

A Bundle of Services Increased Ascertainment of Tuberculosis among HIV-Infected Individuals Enrolled in a HIV Cohort in Rural Sub-Saharan Africa.

Haraka F, Glass TR, Sikalengo G, Gamell A, Ntamatungiro A, Hatz C, Tanner M, Furrer H, Battegay M, Letang E.

PLoS One. 2015 Apr 21;10(4):e0123275. doi: 10.1371/journal.pone.0123275. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0129185.

9.

Is zidovudine first-line therapy virologically comparable to tenofovir in resource-limited settings?

Labhardt ND, Bader J, Lejone TI, Ringera I, Puga D, Glass TR, Klimkait T.

Trop Med Int Health. 2015 Jul;20(7):914-8. doi: 10.1111/tmi.12509. Epub 2015 Apr 2.

10.

Determinants of antiretroviral adherence among HIV positive children and teenagers in rural Tanzania: a mixed methods study.

Nyogea D, Mtenga S, Henning L, Franzeck FC, Glass TR, Letang E, Tanner M, Geubbels E.

BMC Infect Dis. 2015 Jan 31;15:28. doi: 10.1186/s12879-015-0753-y.

11.

Confirmation of the validity of the current characterization of immunochemical reactions by kinetic exclusion assay.

Glass TR, Winzor DJ.

Anal Biochem. 2014 Jul 1;456:38-42. doi: 10.1016/j.ab.2014.04.011. Epub 2014 Apr 18.

PMID:
24751468
12.

Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Cohort Study.

De Geest S, Burkhalter H, Bogert L, Berben L, Glass TR, Denhaerynck K; Psychosocial Interest Group; Swiss Transplant Cohort Study.

Transpl Int. 2014 Jul;27(7):657-66. doi: 10.1111/tri.12312. Epub 2014 Apr 29.

13.
14.

cART prescription trends in a prospective HIV cohort in rural Tanzania from 2007 to 2011.

Franzeck FC, Letang E, Mwaigomole G, Jullu B, Glass TR, Nyogea D, Hatz C, Tanner M, Battegay M.

BMC Infect Dis. 2014 Feb 20;14:90. doi: 10.1186/1471-2334-14-90.

15.

Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study.

von Wyl V, Klimkait T, Yerly S, Nicca D, Furrer H, Cavassini M, Calmy A, Bernasconi E, Böni J, Aubert V, Günthard HF, Bucher HC, Glass TR; Swiss HIV Cohort Study.

PLoS One. 2013 Oct 16;8(10):e77691. doi: 10.1371/journal.pone.0077691. eCollection 2013.

16.
17.

The Swiss Transplant Cohort Study's framework for assessing lifelong psychosocial factors in solid-organ transplants.

De Geest S, Burkhalter H, Berben L, Bogert LJ, Denhaerynck K, Glass TR, Goetzmann L, Kirsch M, Kiss A, Koller MT, Piot-Ziegler C, Schmidt-Trucksäss A; Psychosocial Interest Group, Swiss Transplant Cohort Study.

Prog Transplant. 2013 Sep;23(3):235-46. doi: 10.7182/pit2013250.

PMID:
23996943
18.

Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis.

Antiretroviral Therapy Cohort Collaboration (ART-CC), Shepherd BE, Jenkins CA, Parrish DD, Glass TR, Cescon A, Masabeu A, Chene G, de Wolf F, Crane HM, Jarrin I, Gill J, del Amo J, Abgrall S, Khaykin P, Lehmann C, Ingle SM, May MT, Sterne JA, Sterling TR.

AIDS. 2013 May 15;27(8):1321-9. doi: 10.1097/QAD.0b013e32835faa95.

19.

Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study.

Conen A, Wang Q, Glass TR, Fux CA, Thurnheer MC, Orasch C, Calmy A, Bernasconi E, Vernazza P, Weber R, Bucher HC, Battegay M, Fehr J.

J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):472-8. doi: 10.1097/QAI.0b013e3182a61ea9.

PMID:
23892243
20.

Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery.

Aebi-Popp K, Mulcahy F, Glass TR, Rudin C, Martinez de Tejada B, Bertisch B, Fehr J, Grawe C, Scheibner K, Rickenbach M, Hoesli I, Thorne C; European Collaborative Study in EuroCoord; Swiss Mother & Child HIV Cohort Study.

J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):58-65. doi: 10.1097/QAI.0b013e3182a334e3.

PMID:
23842074
Items per page

Supplemental Content

Loading ...
Write to the Help Desk